Upgrade to SI Premium - Free Trial

ResMed (RMD) Tops Q4 EPS by 1c, Revenues Beat

July 25, 2019 4:27 PM
ResMed (NYSE: RMD) reported Q4 EPS of $0.95, $0.01 better than the analyst estimate of $0.94. Revenue for the quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Earnings Management Comments

Next Articles